Please try another search
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely...
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1047 | 1008 | 1164 | 932 | 1144 | 1357 |
Fund Return | 4.69% | 0.85% | 16.44% | -2.31% | 2.72% | 3.1% |
Place in category | 270 | 26 | 139 | 201 | 107 | - |
% in Category | 89 | 10 | 42 | 91 | 61 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DGC Stock Selection A CHF Acc | 581.75M | 8.90 | 4.64 | 7.99 | ||
Diversified Growth CompanyHorizonte | 149.46M | 2.66 | -2.25 | 0.49 | ||
DGC NS Balanced Class A CHF Acc | 94.13M | 4.22 | -1.57 | 1.53 | ||
DGC NS Balanced Class B CHF Acc | 94.13M | 4.43 | -1.32 | - | ||
DGC Franck Muller Luxury B CHF Acc | 69.8M | -4.55 | -5.76 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Baloise Inv Lux BFI Dynamic CHF R A | 68.54M | 10.39 | -0.41 | 3.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Fundsmith Sustainable Equity Fund I Acc | GB00BF0V6P41 | 8.56 | 2.018 | +1.71% | |
iShares US Medical Devices UCITS USD (Acc) | IE00BMX0DF60 | 7.81 | 6.46 | -0.62% | |
UBS AG | CH0511367242 | 7.65 | - | - | |
DGC Stock Selection A EUR | LU0947862743 | 7.14 | 295.989 | +1.13% | |
iShares MSCI World SRI UCITS ETF USD (Dist) | IE00BDZZTM54 | 7.05 | 9.61 | +0.31% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Neutral | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review